Aster RH. Drug-induced thrombocytopenia. 2nd ed. In: Michelson AD, ed. Platelets. San Diego: Academic Press; 2007: 887–902.10.1016/B978-012369367-9/50811-9Search in Google Scholar
Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 2009;133:309–14.10.5858/133.2.30919195976Search in Google Scholar
Davoren A, Aster RH. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 2006;81:36–44.10.1002/ajh.2049016369980Search in Google Scholar
Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood 2012;119:2209–18.10.1182/blood-2011-11-37629322246036Search in Google Scholar
Warkentin TE. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program 2011;2011:143–9.10.1182/asheducation-2011.1.14322160026Search in Google Scholar
Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580–7.10.1056/NEJMra06646917687133Search in Google Scholar
Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 2007;21:685–96, vi.10.1016/j.hoc.2007.06.005199323617666285Search in Google Scholar
van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf 2004;27:1243–52.10.2165/00002018-200427150-0000715588119Search in Google Scholar
Kaufman DW, Kelly JP, Johannes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714–18.10.1182/blood.V82.9.2714.2714Search in Google Scholar
Tcheng JE, Kereiakes DJ, Lincoff AM, et al. Abciximab readministration: results of the ReoPro Readministration Registry. Circulation 2001;104:870–5.10.1161/hc3301.09453311514371Search in Google Scholar
Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 2010;116:2127–33.10.1182/blood-2010-03-276691Search in Google Scholar
Reese JA, Nguyen LP, Buchanan GR, et al. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer 2013;60: 1975–81.10.1002/pbc.24682Search in Google Scholar
Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 2013;11:169–76.10.1111/jth.12052Search in Google Scholar
Garbe E, Andersohn F, Bronder E, et al. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 2011;68:821–32.10.1007/s00228-011-1184-3Search in Google Scholar
Azuno Y, Yaga K, Sasayama T, Kimoto K. Thrombocytopenia induced by Jui, a traditional Chinese herbal medicine. Lancet 1999;354:304–5.10.1016/S0140-6736(99)01336-7Search in Google Scholar
Ohmori T, Nishii K, Hagihara A, Takeda M, Sekido K. Acute thrombocytopenia induced by jui, a traditional herbal medicine. J Thromb Haemost 2004;2:1479–80.10.1111/j.1538-7836.2004.00786.xSearch in Google Scholar
Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol 2010;84:421–9.10.1111/j.1600-0609.2010.01415.xSearch in Google Scholar
Lavy R. Thrombocytopenic purpura due to Lupinus termis bean. J Allergy 1964;35:386–9.10.1016/0021-8707(64)90065-6Search in Google Scholar
Arnold J, Ouwehand WH, Smith GA, Cohen H. A young woman with petechiae. Lancet 1998;352:618.10.1016/S0140-6736(98)05194-0Search in Google Scholar
Achterbergh R, Vermeer HJ, Curtis BR, et al. Thrombocytopenia in a nutshell. Lancet 2012;379:776.10.1016/S0140-6736(11)61643-7Search in Google Scholar
Davies JK, Ahktar N, Ranasinge E. A juicy problem. Lancet 2001;358:2126.10.1016/S0140-6736(01)07220-8Search in Google Scholar
Belkin GA. Cocktail purpura: an unusual case of quinine sensitivity. Ann Intern Med 1967;66:583–6.10.7326/0003-4819-66-3-5836066916Search in Google Scholar
Christie DJ, Walker RH, Kolins MD, Wilner FM, Aster RH. Quinine-induced thrombocytopenia following intravenous use of heroin. Arch Intern Med 1983;143:1174–5.10.1001/archinte.1983.00350060098016Search in Google Scholar
Taetle R, Browning S. Thrombocytopenia associated with intravenous heroin abuse. West J Med 1979;131:62–4.Search in Google Scholar
Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010;133:466–72.10.1309/AJCPOPQNBP5THKP120154286Search in Google Scholar
Jardim DL, Rodrigues CA, Novis YA, Rocha VG, Hoff PM. Oxaliplatin-related thrombocytopenia. Ann Oncol 2012;23:1937–42.10.1093/annonc/mds07422534771Search in Google Scholar
Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000–2007. Clin Ther 2009;31 Pt 2:2416–32.10.1016/j.clinthera.2009.11.02020110050Search in Google Scholar
Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007;67:4767–73.10.1158/0008-5472.CAN-06-430317510405Search in Google Scholar
Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 2006;81:193–8.10.1002/ajh.2051616493620Search in Google Scholar
Bozec L, Bierling P, Fromont P, et al. Irinotecan-induced immune thrombocytopenia. Ann Oncol 1998;9:453–5.10.1023/A:1008232514137Search in Google Scholar
Fontão-Wendel R, Hoff PM, Lazar A, et al. Immune-mediated pancytopenia induced by oxaliplatin: a case report. Transfusion 2010;50:1453–9.10.1111/j.1537-2995.2010.02600.x20210930Search in Google Scholar
Taleghani BM, Meyer O, Fontana S, et al. Oxaliplatin-induced immune pancytopenia. Transfusion 2005;45:704–8.10.1111/j.1537-2995.2005.04373.x15847658Search in Google Scholar
Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol 2010;3:12.10.1186/1756-8722-3-12285939320346128Search in Google Scholar
James E, Podoltsev N, Salehi E, Curtis BR, Saif MW. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? Clin Colorectal Cancer 2009;8:220–4.10.3816/CCC.2009.n.03719822513Search in Google Scholar
Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Jr. Clinical guideline update on “Immune thrombocytopenia: an evidence based practice guideline developed by the American Society of Hematology.” Blood 2011;117:4190-4207.10.1182/blood-2010-08-30298421325604Search in Google Scholar
McFarland JG. Post-transfusion purpura. In: Popovsky MA, ed. Transfusion Reactions. 4th ed. Bethesda, MD: AABB Press;2009,263-82.Search in Google Scholar
Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol 2008;142:348–60.10.1111/j.1365-2141.2008.07189.x18510692Search in Google Scholar
Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med 2004;164:218–20.10.1001/archinte.164.2.21814744847Search in Google Scholar
George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998;129:886–90.10.7326/0003-4819-129-11_Part_1-199812010-000099867731Search in Google Scholar
George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program 2009:153–8.10.1182/asheducation-2009.1.153441390320008194Search in Google Scholar
Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 1997;52:183–9.10.1007/s0022800502729218924Search in Google Scholar
Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/ IIIa complex. Blood 1994;84:176–83.10.1182/blood.V84.1.176.176Search in Google Scholar
Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood 1991;77:2668–76.10.1182/blood.V77.12.2668.2668Search in Google Scholar
Visentin GP, Wolfmeyer K, Newman PJ, Aster RH. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990;30: 694–700.10.1046/j.1537-2995.1990.30891020326.x2219255Search in Google Scholar
Drug-induced immune thrombocytopenia: results of the testing for drug-dependent platelet-reactive antibodies by the BloodCenter of Wisconsin. Available at: http://ouhsc.edu/ platelets/InternetPostingLab2_18_11Frames.htm. Accessed November 18, 2013.Search in Google Scholar
Kiefel V, Santoso S, Schmidt S, Salama A, Mueller-Eckhardt C. Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion 1987;27:262–5.10.1046/j.1537-2995.1987.27387235635.x3296342Search in Google Scholar
Bougie DW, Benito AI, Sanchez-Abarca LI, Torres R, Birenbaum J, Aster RH. Acute thrombocytopenia caused by sensitivity to the glucuronide conjugate of acetaminophen. Blood 2007;109:3608–9.10.1182/blood-2006-12-06394117409346Search in Google Scholar
Pfueller SL, Bilston RA, Logan D, Gibson JM, Firkin BG. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, and IX. Blood 1988;72:1155–62.10.1182/blood.V72.4.1155.1155Search in Google Scholar
Peterson JA, Nelson TN, Kanack AJ, Aster RH. Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA. Blood 2008;111:1234–9.10.1182/blood-2007-09-112680221475217959856Search in Google Scholar
Peterson JA, Nyree CE, Newman PJ, Aster RH. A site involving the “hybrid” and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood 2003;101:937–42.10.1182/blood-2002-07-233612393510Search in Google Scholar
Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med 2007;356: 904–10.10.1056/NEJMoa06506617329697Search in Google Scholar
Burgess JK, Lopez JA, Berndt MC, Dawes I, Chesterman CN, Chong BH. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes. Blood 1998;92:2366–73.10.1182/blood.V92.7.2366Search in Google Scholar
Gentilini G, Curtis BR, Aster RH. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood 1998;92:2359–65.10.1182/blood.V92.7.2359Search in Google Scholar
Kroll H, Sun QH, Santoso S. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood 2000;96:1409–14.10.1182/blood.V96.4.1409Search in Google Scholar
Christie DJ, Mullen PC, Aster RH. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol 1987;67:213–19.10.1111/j.1365-2141.1987.tb02329.x3676108Search in Google Scholar
Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood 2010;116:3033–8.10.1182/blood-2010-03-277764297460820587782Search in Google Scholar
Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209:149–53.10.1016/j.tox.2004.12.03115767027Search in Google Scholar
Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911–8.10.1111/j.1538-7836.2009.03360.x293518519344362Search in Google Scholar
Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006;108:922–7.10.1182/blood-2006-01-009803189585416861345Search in Google Scholar
Aster RH, Curtis BR, Bougie DW. Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors. Semin Thromb Hemost 2004;30:569–77.10.1055/s-2004-83567715497099Search in Google Scholar
Ries CA, Rosenbaum TJ, Garratty G, Petz LD, Fudenberg HH. Penicillin-induced immune hemolytic anemia. Occurrence of massive intravascular hemolysis. JAMA 1975;233:432–5.10.1001/jama.1975.03260050038017Search in Google Scholar
Aster RH. Can drugs cause autoimmune thrombocytopenic purpura? Semin Hematol 2000;37:229–38.10.1053/shem.2000.8954Search in Google Scholar
Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002;100:2071–6.10.1182/blood.V100.6.2071Search in Google Scholar
Bednar B, Cook JJ, Holahan MA, et al. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood 1999;94: 587–99.10.1182/blood.V94.2.587Search in Google Scholar
Curtis BR, Swyers J, Divgi A, McFarland JG, Aster RH. Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 2002;99:2054–9.10.1182/blood.V99.6.205411877279Search in Google Scholar
Curtis BR, Divgi A, Garritty M, Aster RH. Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2004;2:985–92.10.1111/j.1538-7836.2004.00744.x15140135Search in Google Scholar
Christopoulos C. Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa. Clin Exp Immunol 1994;98:6–11.10.1111/j.1365-2249.1994.tb06598.x15341647923885Search in Google Scholar
Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75: 310–14.10.1172/JCI1116914234423871201Search in Google Scholar
Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood 2003;102: 1670–7.10.1182/blood-2002-07-217512738668Search in Google Scholar
Bougie DW, Birenbaum J, Rasmussen M, Poncz M, Aster RH. Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia. Blood 2009;113:1105–11.10.1182/blood-2008-09-177279263507518948570Search in Google Scholar
